Zoster Eye Disease Study (ZEDS): A multi-center randomized double-masked placebo-controlled study of valacyclovir in immunocompetent subjects with a history of dendriform epithelial keratitis stromal keratitis endothelial keratitis and/or iritis due to Herpes Zoster Ophthalmicus (HZO) within the year prior to enrollment.
Brief description of study
Request to rely on the lead site IRB, see attached documents
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Herpes Zoster Ophthalmicus
-
Age: - 99 Years
-
Gender: All
Updated on
09 Mar 2024.
Study ID: 827758
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting